![Neal Gordon Simon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neal Gordon Simon
Founder at Azevan Pharmaceuticals, Inc.
Neal Gordon Simon active positions
Companies | Position | Start | End |
---|---|---|---|
Azevan Pharmaceuticals, Inc.
![]() Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Director/Board Member | 2010-12-14 | - |
Chief Executive Officer | 1998-12-31 | - | |
Founder | 1998-12-31 | - |
Career history of Neal Gordon Simon
Former positions of Neal Gordon Simon
Companies | Position | Start | End |
---|---|---|---|
University of Strasbourg | Corporate Officer/Principal | 1995-12-31 | - |
Lehigh University | Corporate Officer/Principal | - | - |
Training of Neal Gordon Simon
Rutgers State University of New Jersey | Doctorate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Statistics
International
United States | 4 |
France | 3 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoral
Consumer Services | 5 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Azevan Pharmaceuticals, Inc.
![]() Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
- Stock Market
- Insiders
- Neal Gordon Simon
- Experience